Trial Outcomes & Findings for Adaptive Hip Exoskeleton for Stroke Gait Enhancement (NCT NCT05536739)

NCT ID: NCT05536739

Last Updated: 2026-07-01

Results Overview

This outcome represents the error with which the deep learning model embedded into our hip exoskeleton's microprocessor predicts hip joint moments in stroke patients. Specifically, the coefficient of determination (R²) is computed between the predicted hip joint moments and the ground truth measurements. Ground truth measurements are obtained from a laboratory-grade force plate system and inverse dynamics calculations. For these measures, higher R² values (closer to 1.0) indicate better correlation between predicted and actual hip joint moments. This metric provides a comprehensive assessment of the exoskeleton's ability to accurately estimate hip joint moments in stroke patients during tasks, with improved outcomes representing better assistive capabilities for the user.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

12 participants

Primary outcome timeframe

5 Days

Results posted on

2026-07-01

Participant Flow

Participant milestones

Participant milestones
Measure
Hip Exoskeleton for Stroke Gait Assistance
This study will be conducted on a sample population of stroke subjects (single arm). Subjects will be tested with the hip exoskeleton and baseline.
Overall Study
STARTED
12
Overall Study
COMPLETED
12
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Adaptive Hip Exoskeleton for Stroke Gait Enhancement

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Hip Exoskeleton for Stroke Gait Assistance
n=12 Participants
This study will be conducted on a sample population of stroke subjects (single arm). Subjects will be tested with the hip exoskeleton and baseline.
Age, Continuous
51.2 Years
STANDARD_DEVIATION 11.8 • n=9 Participants
Sex: Female, Male
Female
3 Participants
n=9 Participants
Sex: Female, Male
Male
9 Participants
n=9 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=9 Participants
Race (NIH/OMB)
Asian
0 Participants
n=9 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=9 Participants
Race (NIH/OMB)
Black or African American
6 Participants
n=9 Participants
Race (NIH/OMB)
White
5 Participants
n=9 Participants
Race (NIH/OMB)
More than one race
1 Participants
n=9 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=9 Participants
Region of Enrollment
United States
12 Participants
n=9 Participants
Paretic Side
Right Side
5 Participants
n=9 Participants
Paretic Side
Left Side
7 Participants
n=9 Participants
Stroke Type
Ischemic
7 Participants
n=9 Participants
Stroke Type
Hemorrhagic
4 Participants
n=9 Participants
Stroke Type
Not Reported
1 Participants
n=9 Participants
Time Since Stroke
102.75 Months
STANDARD_DEVIATION 64.06 • n=9 Participants
Height
174.5 Centimeters
STANDARD_DEVIATION 6.6 • n=9 Participants
Weight
93.2 Kilograms
STANDARD_DEVIATION 13.1 • n=9 Participants
Body Mass Index (BMI)
30.7 Kilograms / Meters, Squared
STANDARD_DEVIATION 4.5 • n=9 Participants
Self Selected Walking Speed
0.81 Meters per second
STANDARD_DEVIATION 0.25 • n=9 Participants
Fugl Meyer Assessment - Lower Extremity
24.3 Unit on a scale
STANDARD_DEVIATION 5.3 • n=9 Participants
Mini Balance Evaluations Systems Test (Mini-BESTest)
19.3 Units on a scale
STANDARD_DEVIATION 4.1 • n=9 Participants
Assistive Device
Cane
2 Participants
n=9 Participants
Assistive Device
Ankle Foot Orthosis
2 Participants
n=9 Participants
Assistive Device
Cane and Ankle Mediolateral Support
1 Participants
n=9 Participants
Assistive Device
None
6 Participants
n=9 Participants
Assistive Device
Cane and Ankle Foot Orthosis
1 Participants
n=9 Participants

PRIMARY outcome

Timeframe: 5 Days

Population: This outcome measure was only measured during the hip exoskeleton intervention as it can only be measured if wearing a hip exoskeleton as it is representative of the error with which the deep learning model embedded into the hip exoskeleton microprocessor predicts hip joint moments in stroke patients.

This outcome represents the error with which the deep learning model embedded into our hip exoskeleton's microprocessor predicts hip joint moments in stroke patients. Specifically, the coefficient of determination (R²) is computed between the predicted hip joint moments and the ground truth measurements. Ground truth measurements are obtained from a laboratory-grade force plate system and inverse dynamics calculations. For these measures, higher R² values (closer to 1.0) indicate better correlation between predicted and actual hip joint moments. This metric provides a comprehensive assessment of the exoskeleton's ability to accurately estimate hip joint moments in stroke patients during tasks, with improved outcomes representing better assistive capabilities for the user.

Outcome measures

Outcome measures
Measure
Hip Exoskeleton for Stroke Gait Assistance
n=12 Participants
This study will be conducted on a sample population of stroke subjects (single arm). Subjects will be tested with the hip exoskeleton and baseline.
Temporal Convolutional Network (TCN) Model Performance (Joint Moment Accuracy)
0.7228 Coefficient of determination
Standard Deviation 0.0846

PRIMARY outcome

Timeframe: 5 days

Population: 1 participant was excluded due to self-reported physiological condition unrelated to study intervention. 1 participant excluded due to physical difficulty unrelated to study intervention.

Metabolic energy expenditure will be quantified using an indirect calorimetry system (Parvo Medics, UT) that measures oxygen consumption (VO₂) and carbon dioxide production (VCO₂) during experimental tasks. Measurements will be collected from each participant during a 5-minute baseline standing period followed by level ground walking trials under three conditions: without the exoskeleton, with the exoskeleton in a powered state, and with the exoskeleton in an unpowered state. Metabolic cost will be calculated from respiratory gas exchange data using standard equations for energy expenditure.

Outcome measures

Outcome measures
Measure
Hip Exoskeleton for Stroke Gait Assistance
n=10 Participants
This study will be conducted on a sample population of stroke subjects (single arm). Subjects will be tested with the hip exoskeleton and baseline.
Metabolic Cost for Level Ground Walking
Baseline
1.95 Watts / Kilogram
Standard Deviation 2.45
Metabolic Cost for Level Ground Walking
Hip Exoskeleton
1.85 Watts / Kilogram
Standard Deviation 2.48

PRIMARY outcome

Timeframe: 5 days

Population: 1 participant was excluded due to self-reported physiological condition unrelated to study intervention. 1 participant excluded due to invalid trial data.

Mechanical work performed by the lower limb joints during level walking will be quantified through biomechanical analysis of motion capture data. Joint moments and angular velocities will be derived through inverse dynamics and kinematics, respectively. Joint power, calculated as the product of joint moment and angular velocity, will be integrated with respect to time using trapezoidal integration to determine mechanical work. Positive work will be calculated by integrating positive joint powers, providing comprehensive quantification of joint energy generation at each joint during level walking.

Outcome measures

Outcome measures
Measure
Hip Exoskeleton for Stroke Gait Assistance
n=10 Participants
This study will be conducted on a sample population of stroke subjects (single arm). Subjects will be tested with the hip exoskeleton and baseline.
Biological Joint Work - Level Walking
Baseline
0.17 Watts per Kilogram
Standard Deviation 0.055
Biological Joint Work - Level Walking
Hip Exoskeleton
0.154 Watts per Kilogram
Standard Deviation 0.05

PRIMARY outcome

Timeframe: 5 days

Population: 1 participant was excluded due to self-reported physiological condition unrelated to study intervention. 2 participant excluded due to invalid trial data.

Mechanical work performed by the lower limb joints will be quantified during incline walking through biomechanical analysis of motion capture data. Joint moments and angular velocities will be derived through inverse dynamics and kinematics, respectively. Joint power, calculated as the product of joint moment and angular velocity, will be integrated with respect to time using trapezoidal integration to determine mechanical work. Positive work will be calculated by integrating positive joint powers, providing comprehensive quantification of joint energy generation at each joint during the incline walking.

Outcome measures

Outcome measures
Measure
Hip Exoskeleton for Stroke Gait Assistance
n=9 Participants
This study will be conducted on a sample population of stroke subjects (single arm). Subjects will be tested with the hip exoskeleton and baseline.
Biological Joint Work - Incline Walking
Baseline
0.273 Watts per Kilogram
Standard Deviation 0.089
Biological Joint Work - Incline Walking
Hip Exoskeleton
0.252 Watts per Kilogram
Standard Deviation 0.071

PRIMARY outcome

Timeframe: 5 days

Population: One participant excluded due to self-reported physiological symptoms unrelated to the study intervention.

Mechanical work performed by the lower limb joints will be quantified during stair ascent through biomechanical analysis of motion capture data. Joint moments and angular velocities will be derived through inverse dynamics and kinematics, respectively. Joint power, calculated as the product of joint moment and angular velocity, will be integrated with respect to time using trapezoidal integration to determine mechanical work. Positive work will be calculated by integrating positive joint powers, providing comprehensive quantification of joint energy generation at each joint during the stair ascent task.

Outcome measures

Outcome measures
Measure
Hip Exoskeleton for Stroke Gait Assistance
n=11 Participants
This study will be conducted on a sample population of stroke subjects (single arm). Subjects will be tested with the hip exoskeleton and baseline.
Biological Joint Work - Stair Ascent
Baseline
1.493 Joules per Kilogram per repetition
Standard Deviation 0.375
Biological Joint Work - Stair Ascent
Hip Exoskeleton
1.318 Joules per Kilogram per repetition
Standard Deviation 0.33

PRIMARY outcome

Timeframe: 5 days

Population: 1 participant was excluded due to self-reported physiological condition unrelated to study intervention. 1 participant did not complete the task due to fatigue from the testing session.

Mechanical work performed by the lower limb joints will be quantified during sit to stand through biomechanical analysis of motion capture data. Joint moments and angular velocities will be derived through inverse dynamics and kinematics, respectively. Joint power, calculated as the product of joint moment and angular velocity, will be integrated with respect to time using trapezoidal integration to determine mechanical work. Positive work will be calculated by integrating positive joint powers, providing comprehensive quantification of joint energy generation at each joint during the sit to stand task.

Outcome measures

Outcome measures
Measure
Hip Exoskeleton for Stroke Gait Assistance
n=10 Participants
This study will be conducted on a sample population of stroke subjects (single arm). Subjects will be tested with the hip exoskeleton and baseline.
Biological Joint Work - Sit to Stand
Baseline
0.625 Joules per Kilogram per repetition
Standard Deviation 0.128
Biological Joint Work - Sit to Stand
Hip Exoskeleton
0.416 Joules per Kilogram per repetition
Standard Deviation 0.103

PRIMARY outcome

Timeframe: 5 days

Population: One participant excluded due to self-reported physiological symptoms unrelated to the study intervention. One participant did not complete the task due to fatigue from the testing session.

Mechanical work performed by the lower limb joints will be quantified during a go and grab task through biomechanical analysis of motion capture data. In the go and grab task, participants take several steps, lean forward, and pick up a weighted object from a low surface just above ground level. Joint moments and angular velocities will be derived through inverse dynamics and kinematics, respectively. Joint power, calculated as the product of joint moment and angular velocity, will be integrated with respect to time using trapezoidal integration to determine mechanical work. Positive work will be calculated by integrating positive joint powers, providing comprehensive quantification of joint energy generation at each joint during the go and grab task.

Outcome measures

Outcome measures
Measure
Hip Exoskeleton for Stroke Gait Assistance
n=10 Participants
This study will be conducted on a sample population of stroke subjects (single arm). Subjects will be tested with the hip exoskeleton and baseline.
Biological Joint Work - go and Grab
Baseline
1.389 Joules per Kilogram per repetition
Standard Deviation 0.248
Biological Joint Work - go and Grab
Hip Exoskeleton
1.077 Joules per Kilogram per repetition
Standard Deviation 0.329

SECONDARY outcome

Timeframe: 5 days

Population: One participant excluded due to self-reported physiological symptoms unrelated to the study intervention.

This will be measured as the participant walks a distance of 10 meters across a gait mat at their self-selected (or comfortable) walking speed. This measure will be recorded in seconds with lower values indicating faster speed and higher values indicating slower speeds. Self-selected walking speed is highly correlated with functional ability and dependence.

Outcome measures

Outcome measures
Measure
Hip Exoskeleton for Stroke Gait Assistance
n=11 Participants
This study will be conducted on a sample population of stroke subjects (single arm). Subjects will be tested with the hip exoskeleton and baseline.
10 Meter Walk Test (Self-selected)
Baseline
0.77 Meters per Second
Standard Deviation 0.22
10 Meter Walk Test (Self-selected)
Hip Exoskeleton
0.8 Meters per Second
Standard Deviation 0.17

SECONDARY outcome

Timeframe: 5 days

Population: One participant excluded due to self-reported physiological symptoms unrelated to the study intervention.

This will be measured as the time it takes a participant to rise from a chair, walk three meters at a self-selected pace, turn, walk back to the chair and sit down. The total time taken will be measured in seconds with longer times indicating poorer physical performance. This test assesses functional mobility and dynamic balance.

Outcome measures

Outcome measures
Measure
Hip Exoskeleton for Stroke Gait Assistance
n=11 Participants
This study will be conducted on a sample population of stroke subjects (single arm). Subjects will be tested with the hip exoskeleton and baseline.
The Timed up and go (TUG)
Baseline
15.5 Seconds
Standard Deviation 4.36
The Timed up and go (TUG)
Hip Exoskeleton
15.09 Seconds
Standard Deviation 2.55

SECONDARY outcome

Timeframe: 5 days

Population: One participant excluded due to self-reported physiological symptoms unrelated to the study intervention. One participant excluded due to physical difficulty unrelated to the study intervention

This is a measurement of endurance and functional ability that assesses the participants ability to walk a distance over a time period of 6 minutes. It is measured in distance with greater distances indicating improved levels of endurance and functional ability.

Outcome measures

Outcome measures
Measure
Hip Exoskeleton for Stroke Gait Assistance
n=10 Participants
This study will be conducted on a sample population of stroke subjects (single arm). Subjects will be tested with the hip exoskeleton and baseline.
6 Minute Walk Test
Baseline
258.45 Meters
Standard Deviation 72.92
6 Minute Walk Test
Hip Exoskeleton
282.7 Meters
Standard Deviation 66.65

SECONDARY outcome

Timeframe: 5 days

Population: One participant excluded due to self-reported physiological symptoms unrelated to the study intervention.

The Modified Stroke Impact Scale (SIS) is a self-report questionnaire that evaluates disability and health-related quality of life after stroke. Each item is rated in a 5-point Likert scale in terms of the difficulty the patient has experienced in completing each item. Scores are transformed to a 0-100 scale, with 0 indicating the poorest perceived health status and 100 indicating the best, across domains of disability and health-related quality of life. Higher scores are indicative of improved quality of life.

Outcome measures

Outcome measures
Measure
Hip Exoskeleton for Stroke Gait Assistance
n=11 Participants
This study will be conducted on a sample population of stroke subjects (single arm). Subjects will be tested with the hip exoskeleton and baseline.
Modified Stroke Impact Scale
Baseline
65.8 Units on a scale
Standard Deviation 13.9
Modified Stroke Impact Scale
Hip Exoskeleton
82.29 Units on a scale
Standard Deviation 13.52

SECONDARY outcome

Timeframe: 5 days

Population: One participant excluded due to self-reported physiological symptoms unrelated to the study intervention.

The modified activities specific balance confidence is a self-report measure of balance confidence in performing various activities without losing balance or experiencing a sense of unsteadiness. Confidence is rated for various activities on a scale from 0% to 100% for each activity, with 0% indicative of no confidence and 100% indicative of complete confidence. Scores reflect balance confidence with higher scores indicative of improved balance confidence.

Outcome measures

Outcome measures
Measure
Hip Exoskeleton for Stroke Gait Assistance
n=11 Participants
This study will be conducted on a sample population of stroke subjects (single arm). Subjects will be tested with the hip exoskeleton and baseline.
Modified Activities-specific Balance Confidence
Hip Exoskeleton
73.66 Units on a scale
Standard Deviation 24.74
Modified Activities-specific Balance Confidence
Baseline
58.76 Units on a scale
Standard Deviation 19.69

SECONDARY outcome

Timeframe: 5 days

Population: One participant excluded due to self-reported physiological symptoms unrelated to the study intervention.

This will be measured as the participant walks on a treadmill at their fastest and safest walking speed. This measure will be recorded in meters/seconds with higher values indicating faster speed and lower values indicating slower speeds.

Outcome measures

Outcome measures
Measure
Hip Exoskeleton for Stroke Gait Assistance
n=11 Participants
This study will be conducted on a sample population of stroke subjects (single arm). Subjects will be tested with the hip exoskeleton and baseline.
Fast Self-selected Walking Speed
Hip Exoskeleton
1.01 Meters per Second
Standard Deviation 0.25
Fast Self-selected Walking Speed
Baseline
0.95 Meters per Second
Standard Deviation 0.2

Adverse Events

Hip Exoskeleton for Stroke Gait Assistance - Baseline Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Hip Exoskeleton for Stroke Gait Assistance - Hip Exoskeleton Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Aaron Young

Georgia Institute of Technology

Phone: 404-385-5306

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place